Home/Filings/4/0001209191-21-017590
4//SEC Filing

RASMUSSEN HENRIK S MD 4

Accession 0001209191-21-017590

CIK 0001564824other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:55 PM ET

Size

24.9 KB

Accession

0001209191-21-017590

Insider Transaction Report

Form 4
Period: 2021-03-01
RASMUSSEN HENRIK S MD
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2021-03-03$112.83/sh1,952$220,244101,819 total
  • Sale

    Common Stock

    2021-03-03$113.00/sh20,000$2,260,000103,771 total
  • Exercise/Conversion

    Common Stock

    2021-03-03$1.16/sh+20,000$23,250123,771 total
  • Tax Payment

    Common Stock

    2021-03-02$117.82/sh1,316$155,051103,771 total
  • Sale

    Common Stock

    2021-03-02$117.32/sh20,000$2,346,400105,087 total
  • Exercise/Conversion

    Common Stock

    2021-03-02$1.16/sh+20,000$23,250125,087 total
  • Sale

    Common Stock

    2021-03-01$120.66/sh20,000$2,413,200105,087 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$1.16/sh+20,000$23,250125,087 total
  • Exercise/Conversion

    Stock Option (Right to buy)

    2021-03-0320,000332,000 total
    Exercise: $1.16Exp: 2027-10-02Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to buy)

    2021-03-0220,000352,000 total
    Exercise: $1.16Exp: 2027-10-02Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to buy)

    2021-03-0120,000372,000 total
    Exercise: $1.16Exp: 2027-10-02Common Stock (20,000 underlying)
Footnotes (7)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $111.30 to $115.09 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
  • [F2]Includes shares of common stock purchased under the Company's 2018 Employee Stock Purchase Plan.
  • [F3]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $111.00 to $116.78 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
  • [F4]Shares withheld to satisfy the tax obligations by the reporting person in connection with the vesting of RSUs.
  • [F5]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $115.85 to $121.83 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
  • [F6]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. This transaction was executed in multiple trades at prices ranging from $117.445 to $126.76 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
  • [F7]On October 2, 2017, the Reporting Person was granted an option to purchase 392,000 ordinary shares pursuant to the Company's 2018 Equity Incentive Plan. The option vests as to one-fourth of the shares on October 2, 2018, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Issuer

Allakos Inc.

CIK 0001564824

Entity typeother

Related Parties

1
  • filerCIK 0001271905

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:55 PM ET
Size
24.9 KB